Pharmaceutical company Polymed set to own 90% of PendraCare Group for approximately ₹188.5 crores

========================================================

The healthcare sector and related industries are witnessing significant changes and advancements across the globe. Here's a summary of some of the key developments in the field.

In India, the government is taking steps to strengthen the emergency layer within the public health framework. Meanwhile, the tax structure for both insurance and medical devices in the healthcare sector is undergoing reforms. The Indian government has recently implemented GST cuts on healthcare and medicines, a move that has been met with approval from various companies. Hindustan Unilever, Nestlé, and Godrej Industries, among others, expect increased sales, while insurance firms are highlighting the abolition of GST on individual life and health insurance products.

In the realm of technology, lung cancer detection is being influenced by new technologies such as CBCT. These new-age technologies are shaping the future of lung cancer diagnosis, offering hope for those affected by the disease.

Edwards Lifesciences, a prominent player in the healthcare industry, has seen continued growth in its Transcatheter Aortic Valve Replacement (TAVR) division. GlobalData, a company specialising in data and analytics, has made a statement about this growth, attributing it to the market acceleration. However, the exact extent of the growth has not been specified in the statement.

GlobalData has also highlighted a decline in sexual health testing in the US. This revelation comes as World Sexual Health Day approaches, raising awareness about the importance of regular testing and open discussions about sexual health.

The global market for TAVR is also experiencing accelerated growth, a trend that the industry is responding to. Edwards Lifesciences' growth in this division is a testament to this market trend.

Lastly, reforms in the tax structure for insurance in the healthcare sector aim to make insurance products more accessible for the public, furthering the government's commitment to improving healthcare affordability in India.

Pharmaceutical company Polymed set to own 90% of PendraCare Group for approximately ₹188.5 crores